StonvexLoading…
StonvexStonvexStonvexCore line items from ZS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-30 | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Annual 2025 2025-07-31 |
|---|---|---|---|---|
Revenue | $2.45B | $1.60B | $788.11M | $2.67B |
Operating Income | $-117.78M | $-88.14M | $-36.36M | $-128.46M |
Net Income | $-59.81M | $-45.93M | $-11.62M | $-41.48M |
EPS (Diluted) | $-0.37 | $-0.29 | $-0.07 | $-0.27 |
Total Assets | $7.10B | $6.75B | $6.50B | $6.42B |
Total Liabilities | $4.73B | $4.56B | $4.52B | $4.62B |
Cash & Equivalents | $982.11M | $1.20B | $1.34B | $2.39B |
Free Cash Flow OCF − CapEx | $772.90M | $617.29M | $430.97M | $808.20M |
Shares Outstanding | 161.71M | 160.57M | 159.47M | 158.30M |